API | pegademase-bovine

pegademase-bovine (Adagen) Report issue

Animal product Orphan Drug ^FDA Approved ^FDA

AACT ChEMBL DrugBank Drugs@FDA MeSH

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
pegademase bovine

More Chemistry

Pharmacology

Mechanisms of Action:
- Adenosine deaminase (Bos taurus) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Parenteral
Pro Drug: No

Organizations (4)

Research & Development (4)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (2)

Approved Indications (1)

Severe Combined Immunodeficiency (approved 1990)

Experimental Indications - Clinical Trial Phases 1-4 (2)

Adenosine Deaminase (Phase 3)

Severe Combined Immunodeficiency (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 2
# of Trial Organizations: 4

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue